King Keytru­da: Mer­ck­'s PD-1 star scores #1 po­si­tion and $22B+ pre­dic­tion in an­oth­er top 10 block­buster list for 2025

Pre­dict­ing which of the cur­rent block­busters will as­cend to new heights is any­one’s game, and one that high­lights the cur­rent dy­nam­ics of the in­dus­try. On Fri­day it’s Glob­al­Da­ta’s turn to pick out the ther­a­pies that it be­lieves will come out on top in some in­tense­ly com­pet­i­tive spaces.

Hu­mi­ra may still top the chart for best-sell­ing drugs in the world, but Keytru­da is set to over­take the shrink­ing fran­chise in around five years time — with four oth­er drugs set to get ahead of Ab­b­Vie’s biggest cash cow.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.